HCP1701
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HCP1701, covering 2020-11-30 to 2020-11-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia [Phase 3]